These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 18208823)

  • 1. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
    Caro XJ; Winter EF; Dumas AJ
    Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
    Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
    Harbo T; Andersen H; Jakobsen J
    Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
    Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
    J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
    Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP.
    Iijima M; Tomita M; Morozumi S; Kawagashira Y; Nakamura T; Koike H; Katsuno M; Hattori N; Tanaka F; Yamamoto M; Sobue G
    Neurology; 2009 Oct; 73(17):1348-52. PubMed ID: 19776380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia.
    Kimura A; Yoshino H; Yuasa T
    J Neurol Sci; 2005 Apr; 231(1-2):89-93. PubMed ID: 15792827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
    Mohamed AR; Rodriguez-Casero MV; Ryan MM
    Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain as the presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    Boukhris S; Magy L; Khalil M; Sindou P; Vallat JM
    J Neurol Sci; 2007 Mar; 254(1-2):33-8. PubMed ID: 17286985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
    Dionne A; Nicolle MW; Hahn AF
    Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Lin CS; Krishnan AV; Park SB; Kiernan MC
    Arch Neurol; 2011 Jul; 68(7):862-9. PubMed ID: 21747028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset and course of chronic inflammatory demyelinating polyneuropathy.
    Mygland A; Monstad P; Vedeler C
    Muscle Nerve; 2005 May; 31(5):589-93. PubMed ID: 15742374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis.
    Rajabally YA; Jacob S
    Muscle Nerve; 2008 Jul; 38(1):855-60. PubMed ID: 18508343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.